Title : FK506 induces chondrogenic differentiation of clonal mouse embryonic carcinoma cells, ATDC5.

Pub. Date : 2002 Feb 22

PMID : 11890899






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 FK506 (Tacrolimus) and cyclosporin A exert their immunosuppressive effects via a common mechanism, calcineurin inhibition, after binding to intracellular proteins termed immunophilins: FK506-binding protein (FKBP) and cyclophilin. Tacrolimus FK506 binding protein 1a Mus musculus
2 FK506 (Tacrolimus) and cyclosporin A exert their immunosuppressive effects via a common mechanism, calcineurin inhibition, after binding to intracellular proteins termed immunophilins: FK506-binding protein (FKBP) and cyclophilin. Tacrolimus FK506 binding protein 1a Mus musculus
3 FK506 (Tacrolimus) and cyclosporin A exert their immunosuppressive effects via a common mechanism, calcineurin inhibition, after binding to intracellular proteins termed immunophilins: FK506-binding protein (FKBP) and cyclophilin. Tacrolimus FK506 binding protein 1a Mus musculus
4 FK506 (Tacrolimus) and cyclosporin A exert their immunosuppressive effects via a common mechanism, calcineurin inhibition, after binding to intracellular proteins termed immunophilins: FK506-binding protein (FKBP) and cyclophilin. Tacrolimus FK506 binding protein 1a Mus musculus
5 Rapamycin, an immunosuppressant that binds to FKBP, antagonized the effect of FK506. Tacrolimus FK506 binding protein 1a Mus musculus
6 Taken together, these results suggest that FK506 induces chondrogenic differentiation of ATDC5 cells via a calcineurin-independent mechanism, after binding to FKBP. Tacrolimus FK506 binding protein 1a Mus musculus